Synthesis, characterization and in vitro biocompatibility assessment of a novel tripeptide hydrogelator, as a promising scaffold for tissue engineering applications by Pospišil, Tihomir et al.
Supporting information
Synthesis, Characterization and In Vitro Biocompatibility Assessment of Novel Tripeptide 
Hydrogelator as a Promising Scaffold for Tissue Engineering Applications
Tihomir Pospišil,a Lejla Ferhatović Hamzić,b Lada Brkić Ahmed,b Marija Lovrić,b Srećko Gajović*b and Leo Frkanec*a
aLaboratory for Supramolecular Chemistry, Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Bijenička 54, 10000 Zagreb, 
Croatia.E-mail: frkanec@irb.hr
bCroatian Institute for Brain Research, University of Zagreb, School of Medicine, Šalata 12, 10000 Zagreb, Croatia. E-mail: srecko.gajovic@cmj.hr
Synthesis and characterization of Ac-L-Phe-L-Phe-L-Ala-NH2
Ac-L-Phe-L-Phe-L-Ala-NH2 was synthesized according to Scheme S-1.
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Scheme S-1  a) DCC, DMAP, Et3N;  b) TFA/CH2Cl2;  c) CH2Cl2;  d)Et3N;  e) NH3/MeOH
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Experimental procedures: syntheses of compounds 1–6 and the corresponding analytical 
data
General 
Melting points were determined on Kofler stage and are uncorrected. 1H and 13C NMR spectra 
were recorded on the Bruker Advance 300 MHz spectrometer, 1H operating at 300.13 MHz 
and 13C at 75.475 MHz. Proton chemical shifts were referenced to tetramethylslane (TMS) as 
an internal standard, whereas 13C chemical shifts were referenced to the solvent signal δ13 
C(DMSO-d6) = 39.5 ppm. Sample concentration was approx. 20 mg mL–1. FTIR spectra were 
recorded on an ABB Bomen MB 102 FTIR-spectrometer. Optical rotations were measured on 
an Optical Activity AA-10 Automatic Polarimeter in a 1 dm cell at 589 nm. Thin-layer 
chromatography (t.l.c.) was performed on Merck Kieselgel HF254 plastic sheets and spots 
were made visible using a UV lamp (254 nm) or I2 vapours. Preparative T. L. C. was 
performed on silica gel (type 60 F254, Merck), the plates were activated at 110 °C for 1 h. 
HRMS analyses were carried out on a Bruker Ultraflex MALDI TOF/TOF (Bruker, Bremen) 
mass spectrometer, in reflectron positive mode using -Cyano-4-hydroxycinnamic acid (FLUKA) 
as a matrix. High‐resolution mass spectra were obtained by internal calibration using Verapamil 
and Leu-enkephalin as internal standards. Transmission electron micrographs were taken on an 
EM10A Zeiss transmission electron microscope (TEM). A small amount of sample was placed on 
carbon-coated grid (copper, 100 mesh). The sample was negatively stained with PWK 
(dipotassium phosphotungstate) and Pd shadowing. Reagents were purchased from Aldrich or 
Fluka and were used without further purification. All solvents were purified and dried 
according to standard procedures. The physiological saline for parenteral (intravenous) 
application was purchased from Croatian Institute for Transfusion Medicine (Petrova 3, 
10000 Zagreb) with pH range from 4.5 to 7.0 (measured pH was 6.12). The plastic used for 
cell culturing were from Sarstedt (Germany). Dulbecco's modified free medium was 
purchased from Lonza (Verviers, Belgium). Quant-iT™ PicoGreen® dsDNA Kit was 
obtained from Promega (Madison, WI USA). LIVE/DEAD Cell Imaging Kit 488/570, 
Molecular Probes was from Thermo Fisher Scientific (Waltham, MA USA).
1. Boc-L-Phe-L-Ala-OMe (1)s1
Compound 1 is synthesized according to the literature.s1
1H-NMR (CDCl3): 7.32-7.19 (m, 5H, Ph), 6.41 (d, 1H, J = 6.90, NHC*H), 4.98 (bs, 1H,  
NHC*H), 4.52 (dt as quintet, 1H, J = 7.20, C*HPhe), 4.35 (d, 1H, J = 6.90, C*HAla), 3.71 (s, 
3H, OCH3), 3.07 (dd, 2H, J = 6.6, 2.4, CH2Ph), 1.41 (s, 9H, C(CH3)3), 1.35 (d, 3H, J = 7.1, 
CH3Ala).
Fig. S-1 1H-NMR of Boc-L-Phe-L-Ala-OMe
2. L-Phe-L-Ala-OMe (2)s2
Compound 2 is synthesized according to the literature.s2
1H-NMR (CDCl3): 7.77 (d, 1H, J = 7.10, NHC*H), 7.34-7.21 (m, 5H, Ph), 4.60 (dt as quintet, 
1H, J = 7.30, C*HAla), 3.74 (s, 3H, OCH3), 3.64 (dd, 1H, J = 4.0, 9.2, C*HPhe), 3.25 (dd, 1H, J 
= 3.90, 13.80, CH2Ph), 2.73 (dd, 1H, J = 9.30, 13.70, CH2Ph), 1.44 (s, 2H, NH2),  1.39 (d, 3H, 
J = 7.20, CH3Ala). 
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Fig. S-2  1H-NMR of  L-Phe-L-Ala-OMe
3. Boc-L-Phe-L-Phe-L-Ala-OMe (3)s3
To a solution of Boc-Phe-OSu (1.00 g, 2.76 mmol) in a mixture of dry dioxane and CH2Cl2 
(35 ml), Phe-Ala-OMe (0.69 g, 2.76 mmol) was added and stirred at room temperature 
overnight. The reaction mixture was evaporated and water (25 mL) and EtOAc (25 mL) 
added. The layers were separated, aqueous one extracted with 25 mL EtOac, the combined 
extracts were washed with water, dried (Na2SO4) and evaporated to the white solid residue 
that had to be chromatographically purified (CH2Cl2 : MeOH = 50:1) to give additional pure 
Boc-Phe-Phe-Ala-OMe (0.85 g, 62 %). 1H-NMR (CDCl3): 7.31-7.07 (m, 10H, 2 x Ph), 6.35 
(bs, 2H, 2 x NHC*H), 4.79 (bs, 1H, NHC*H),  4.61 (dd, 1H, J = 7.1, 13.8, C*HPhe), 4.45 (dt 
as quintet, 1H, J = 7.20, C*HPhe ), 4.30 (d, 1H, J = 6.30, C*HAla), 3.71 (s, 3H, OCH3), 3.16-
2.89 (m, 4H, 2 x CH2Ph), 1.34 (s, 9H, C(CH3)3), 1.31 (d, 3H, J = 7.20, CH3Ala). Compound 3 
was obtained previously by the DCC method,s3 the characterization data are in accordance 
with the earlier described in the literature.s3
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Fig. S-3 1H-NMR of  Boc- L-Phe - L-Phe-L-Ala-OMe
4. L-Phe-L-Phe-L-Ala-OMe (4)4
To a solution of Boc-Phe-Ala-OMe (0.793 g, 1.59 mmol) in dry CH2Cl2 (5 mL) cooled down 
in an ice-bath, TFA (1.59 mL) was added, and the reaction mixture stirred for 0.5 h at 0 oC 
and at room temperature overnight. The reaction mixture was evaporated, some CH2Cl2 (15 
mL) were added and the mixture neutralized with 10 % KHCO3 under cooling in an ice-bath. 
The layers were separated, aqueous one extracted with 2 x 15 mL CH2Cl2, the combined 
extracts were washed with water, dried (Na2SO4) and evaporated to give Phe-Phe-Ala-OMe 
(0.63 g, 92 %). 1H-NMR (DMSO-d6): 8.48 (d, 1H, J = 7.1, NHC*H), 8.01 (d, 1H, J = 8.5, 
NHC*H), 7.27-7.13 (m, 10H, 2xPh), 4.61 (dd, 1H, J = 8.4, 13.2, C*HPhe), 4.29 (dt as quintet, 
1H, J = 7.2, C*HAla ), 3.02-2.77 (m, 4H, 2x CH2Ph), 1.63 (bs, 2H, NH2), 1.29 (d, 3H, J = 7.3, 
CH3Ala), Compound 4 was obtained previously by deprotection of Boc-Phe-Ala-OMe (3) with 
formic acid,s4 the characterization data are in accordance with the earlier described in the 
literature.s4
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Fig. S-4 1H-NMR of  L-Phe-L-Phe-L-Ala-OMe
5. Ac- L-Phe-L-Phe-L-Ala-OMe (5)
To a suspension of L-Phe-L-Phe-L-Ala-OMe (0.578 g, 1.45 mmol) in dry CH2Cl2 (10 mL) 
cooled down in ice-bath, Et3N (0.203 mL, 0.146 g, 1.45 mmol) and acetyl chloride (0.103 mL, 
0.114 g, 1.45 mmol) was added dropwise. The reaction mixture was stirred 1 h at 0 °C and at 
room temperature overnight. The reaction mixture was cooled down in an ice-bath, water (25 
mL) added and the layers separated. Organic layer was washed with 5 % NaHCO3, water, 1 M 
HCl and water, dried (Na2SO4) and evaporated to give Ac-L-Phe-L-Phe-L-Ala-OMe (0.579 g, 
92 %).1H-NMR (DMSO-d6): 8.34 (d, 1H, J = 7.00, NHC*H), 7.97(dd, 2H, J = 8.30, 14,30, 
2xNHC*H), 7.27-7.14 (m, 10H, 2 x Ph), 4.54 (dt, 1H, J = 4.70, 8.90, C*HPhe), 4.47-4.41(m, 
1H, C*HPhe),  4.29 (dt as quintet, 1H, J = 7.20, C*HAla), 3.62 (s, 3H, OCH3), 3.05 (dd, 1H, J 
=4.6, 14.0, 2 x CH2Ph), 2.92 (dd, 1H, J = 4.4, 13.9, 2 x CH2Ph), 2.81 (dd, 1H, J = 9.3, 14.0, 2 
x CH2Ph), 2.65 (dd, 1H, J = 10.0, 13.9, 2 x CH2Ph), 1.72 (s, 3H, COCH3), 1.29 (d, 3H, J = 
7.30, CH3).  13C-NMR (DMSO-d6): 172.78, 171.13, 170.76, 169.07 (4 x CO), 137.95, 137.56, 
129.22, 129.03, 127.98, 127.93, 126.23, 126.11 (2 x Ph), 53.80, 53.41 (2 x C*HPhe), 51.83 
(OCH3), 47.59 (C*HAla), 37.42, 37.28 (2 x CH2Ph), 22.38 (COCH3), 16.86 (CH3); IR(KBr):  
ν = 3278 (NH), 1740 (COOMe), 1638 (amide I), 1537 (amide II) cm-1; m.p. 214-216 0C;
+29° (c = 0.02 in MeOH). HRMS: m/z [M+Na]+ exact mass, C24H29N3O5Na: 
 [𝛼]𝑅𝑇
𝐷
=
462.2005, found: 462.1999.
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Fig. S-5 1H-NMR of  Ac-L-Phe-L-Phe-L-Ala-OMe
Fig. S-6 13C-NMR of  Ac-L-Phe-L-Phe-L-Ala-OMe
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Fig. S-7  HRMS spectra of  Ac-L-Phe-L-Phe-L-Ala-OMe
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Fig. S-8  IR spectrum of  Ac-L-Phe-L-Phe-L-Ala-OMe
6. Ac- L-Phe-L-Phe-L-Ala-NH2 (6)
L-Phe-L-Phe-L-Ala-OMe (0.573 g, 1.30 mmol) was dissolved in saturated methanol solution 
of ammonia and held for seven days at 4 °C. Final product Ac-L-Phe-L-Phe-L-Ala-NH2 
precipitated from the solution (0.540 g, 98%). 1H-NMR (DMSO-d6): 8.08 (d, 1H, J = 8.00, 
NHC*H), 8.00 (d, 1H, J = 8.03, NHC*H), 7.93 (d, 1H, J = 7.50, NHC*H), 7.29-7.10 (m, 
10H, 2 x Ph), 6.99 (bs, 1H, NHNH2), 4.56-4.39  (m, 2H, 2 x C*HPhe), 4.19 (dt as quintet, 1H, J 
= 7.1, C*HAla),  3.11-2.60 (m, 4H, 2 x CH2Ph), 1.72 (s, 3H, COCH3), 1.21 (d, 3H, J = 7.10, 
CH3Ala). 13C-NMR (DMSO-d6): 173.87, 171.30, 170.28, 169.08 (4 x CO), 137.94, 137.66, 
129.20, 129.04, 128.01, 127.93, 126.22, 126.12 (2 x Ph), 53.84, 53.83 (2 x C*HPhe), 48.00 
(C*HAla), 37.25, 37.18 (2 x CH2Ph), 22.37 (COCH3), 18.31 (CH3). ); IR(KBr): ν = 3277 
(NH), 1679 (CONH2), 1626 (amide I), 1544 (amide II) cm-1; Elem. Anal. Calcd. (%) for 
C23H28N4O4 (424.49): C 65.08 H 6.65 N 13.2; found C 65.09 H 6.48  N 13.0; m.p. 243-245 °C, 
  -18° (c = 0.02 in EtOH)
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Fig. S-9 1H-NMR of  Ac- L-Phe-L-Phe-L-Ala-NH2
Fig. S-10  13C-NMR of  Ac- L-Phe-L-Phe-L-Ala-NH2
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Fig. S-11 IR spectrum of  Ac-L-Phe-L-Phe-L-Ala-NH2
Preparation of the Ac-L-Phe-L-Phe-L-Ala-NH2 tripeptide hydrogel 
Tripeptide sample was slowly heated to 80 ºC to dissolve in saline and then allowed to cool 
down to room temperature and form an opaque hydrogel at the concentration of 2.64 mg ml-1 
within 20 minutes. The “tube inversion method in which the glass vial was turned upside 
down,  provides strong visual evidence of the formation of stabile hydrogel which is able to 
support its own weight.
Rheometry
Dynamic viscoelastic and time evolution measurements were carried out with an Anton Paar 
rheometer (MCR 301), by using a parallel-plate geometry (the plate diameter was 25 mm and 
the gap width was 300 μm). All viscoelastic measurements were performed at (25 °C). 
Tripeptide sample was slowly heated to dissolve in saline and then allowed to cool down and 
form a hydrogel at the concentration of 2.64 mg ml-1. A gap of 300 μm was set, a constant 
strain of 2% applied, and a frequency of 10 rad/s was used. A portion of gel was set on a 
sensor plate. Over a period of an hour, storage (elastic, G') and loss (viscous G'') moduli were 
measured and reported as a function of time. 
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The Figure S-12. shows the storage modulus (G′) and loss modulus (G″) of the hydrogel 
prepared from the tripeptide Ac-Phe-Phe-Ala-NH2 as a function of time.
Fig S-12 Dynamic time sweep rheological data of Ac-Phe-Phe-Ala-NH2 hydrogel (c = 2.64 
mg ml-1).
In vitro screening of cell viability and proliferation of the tripeptide based hydrogel
Freshly prepared Ac-L-Phe-L-Phe-L-Ala-NH2 tripeptide hydrogel in minimal gelation 
concentration was left 20 min to cool down to 37 °C in the water bath. HEK293T cells were 
grown in DMEM medium supplemented with 1% Pen/Strep, 1% L-glutamine and 10% Fetal 
Bovine Serum. After reaching 80% confluency, cells were trypsinized and centrifugated at 
300 x g for 5 minutes. After centrifugation, the medium was aspirated and the cell pellet was 
resuspended in Ac-L-Phe-L-Phe-L-Ala-NH2 tripeptide hydrogel at 37 °C in concentration 
1x106cells/ml. Cells encapsulated in the hydrogel were seeded to 24-well plates, with each 
well containing 150 µl of the heterogeneous cell/hydrogel mixture, and then 600 µl of total 
medium was added carefully to each well to avoid disturbation of the mixture. Cells were also 
seeded at the same concentration in Matrigel (Croning) hydrogel, which was used as positive 
control, together with pure total medium. Latex rubber was used as negative control. Obtained 
results are expressed as mean of four independent experiments each performed in a triplicate. 
Cells were kept for 5 days in humidified atmosphere at 37 °C with 5% of CO2. Samples were 
taken on day 0 and day 5 of the experiment.To determine the total cell number in samples, we 
used Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen). Cells were washed with PBS, 
cell/hydrogel mixtures were broken by adding the 1 ml PBS to each well and vigorously 
titurating the mixture for 20 times. After that, the obtained solution was centrifuged at 300 x g 
for 5 min and PBS containing disrupted gel was aspirated. Cells were then resuspended  in 
250 µL of MiliQ water and left for 1h at 37 °C in the water bath. Cells were then stored at -80 
°C until analysis with spectrofluorometer. Prepared samples were sonicated in the ultrasound 
waterbath, mixed with TE-buffer and PicoGreen colour, incubated in dark for 10 min and the 
fluorescence was read in a fluorescent microplate reader (Fluoroskan Ascent FL, Thermo 
Electron Corporation) at 485 nm excitation and 538 nm emission. The exact cell number was 
determined using HEK293T cell number standards. 
To determine cell viability we used LIVE/DEAD Viability/Cytotoxicity Assay. Cells were 
incubated with a mixture of calcein-AM (live) and ethidium homodimer-1 (dead) for 15 
minutes and then observed under Axiovert 200 fluorescent microscope with the 10x objective. 
Five micrographs of green fluorescence (live cells) and red fluorescence (dead cells) were 
taken per each well. Micrographs were analysed with Fiji software and percentage of live 
cells was calculated per each field of view.
Transfection
To observe cell morphology, cells were transfected transiently with tubulin-mCherry plasmid,  
by electroporation using Nucleofector Kit R (Lonza, Basel, Switzerland) with the 
Nucleofector 2b Device (Lonza, Basel, Switzerland), using the high-viability O-005 
programme. Transfection protocol provided by the manufacturer was followed. In all, 1x106 
cells and 2 μg of plasmid DNA were used. Transfection was performed 72 h before imaging.
Confocal microscopy
Cells encapsulated in SAP hydrogel and cells grown in pure medium were imaged by using a 
Leica TCS SP8 X laser 15 scanning confocal microscope with 100x oil immersion objective 
(Leica, Wetzlar, Germany) heated with an objective integrated heater system (Okolab, 
Burlingame, CA, USA). Excitation and emission lights were separated with AOBS (Acousto-
Optical Beam Splitter, Leica, Wetzlar, Germany). Cells were maintained at 37 °C in Okolab 
stage top heating chamber (Okolab, Burlingame, CA, USA). For excitation, gated STED 
supercontinuum visible white light laser (WLL) 575 nm was used. Emission of mCherry was 
detected with HyD (hybrid) detector in range 585–665 nm. Pinhole diameter was set to 0.8 
μm. Images were acquired at 20 focal planes with 1 μm spacing and 400 Hz unidirectional 
xyz scan mode. In addition, both groups of cells were imaged under bright light using 20x dry 
objective. 
Fig. S-13 HEK293Tcells transfected with tubulin-mCherry, grown in medium and observed 
under confocal microscope 72h after. Cells are adhered to the bottom of the well and are all 
visible in same z planes. Magnification 100x, scale bar applies to all.
Statistical analysis
Statistical analysis (GraphPad Prism; GraphPad Software, San Diego, CA, USA) was 
performed using one-way analysis of variance followed by unpaired T-test, and significance 
was set at p <0.05.
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